Intensified Neoadjuvant Chemoradiotherapy for Patients with Potentially Resectable Esophageal Cancer: A Retrospective Cohort Study

Background Neoadjuvant treatment consisting of five cycles of carboplatin and paclitaxel with concurrent radiotherapy (41.4 Gy), followed by esophagectomy, is the standard treatment for resectable esophageal cancer in The Netherlands. It remains unclear whether intensification of neoadjuvant therapy...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of surgical oncology 2020-05, Vol.27 (5), p.1520-1528
Hauptverfasser:	Boers, Jorianne, Joldersma, Annalie, van Dalsen, Annette D., Wiegman, Erwin M., Schenk, B. Ed, de Graaf, Jacques C., Pierik, Engelbertus G. J. M., Timmer, Paul R., de Groot, Jan Willem B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cancer Carboplatin Carboplatin - administration & dosage Chemoradiotherapy Chemotherapy Cohort analysis Disease-Free Survival Esophageal cancer Esophageal Neoplasms - therapy Esophagectomy Esophagogastric Junction - surgery Esophagus Female Health risk assessment Humans Kaplan-Meier Estimate Male Medicine Medicine & Public Health Middle Aged Neoplasm Staging Netherlands Oncology Paclitaxel Paclitaxel - administration & dosage Radiation therapy Retrospective Studies Surgery Surgical Oncology Survival Survival Rate Thoracic Oncology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!